Medical College of Wisconsin
CTSIResearch InformaticsREDCap

COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022 May 06;10(13):3969-3980

Date

06/07/2022

Pubmed ID

35665122

Pubmed Central ID

PMC9131221

DOI

10.12998/wjcc.v10.i13.3969

Abstract

Coronavirus disease 2019 (COVID-19) pneumonia outbreak started in December 2019. On March 12, 2020, the World Health Organization (WHO) declared that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitutes a pandemic, and as of May 2021, SARS-CoV-2 has infected over 167.3 million patients, including 3.4 million deaths, reported to WHO. In this review, we will focus on the relationship between SARS-CoV-2 infection and the liver. We will discuss how chronic liver diseases affect the COVID-19 disease course and outcomes. We will also discuss the SARS-CoV-2 effects on the liver, mechanisms of acute liver injury, and potential management plans.

Author List

Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R

Author

Ismail Elkhattib MBA, MD Assistant Professor in the Medicine department at Medical College of Wisconsin